Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Annals of neurology Hoekstra, J. G., Hipp, M. J., Montine, T. J., Kennedy, S. R. 2016; 80 (2): 301-306

Abstract

Mitochondrial dysfunction and oxidative damage are commonly associated with early stage Alzheimer disease (AD). The accumulation of somatic mutations in mitochondrial DNA (mtDNA) has been hypothesized to be a driver of these phenotypes, but the detection of increased mutation loads has been difficult due to a lack of sensitive methods. We used an ultrasensitive next generation sequencing technique to measure the mutation load of the entire mitochondrial genome. Here, we report a significant increase in the mtDNA mutation frequency in the hippocampus of early stage AD, with the cause of these mutations being consistent with replication errors and not oxidative damage. Ann Neurol 2016;80:301-306.

View details for DOI 10.1002/ana.24709

View details for PubMedID 27315116

View details for PubMedCentralID PMC4982791